Medical communities should take
note this is a paradigm shift in natural medicine.
Yes, there is a
concerning increase in HIV infections among students in Malaysian institutions
of higher learning (IPTAs), with 222 new cases reported last year alone. This
brings the total number of HIV-positive IPT students between 2021 and 2024 to
1,091. The Malaysian AIDS Council has highlighted that a significant portion,
44%, of those infected with HIV are young people aged 20-29.
Rising numbers: 👆👆
The 222 new cases
reported last year (2024) among IPT students adds to the total of 1,091 cases
reported between 2021 and 2024.
The majority of these new cases are among students aged 18-19, highlighting a shift in the demographics of new infections.
This increase is particularly concerning as it suggests that existing HIV prevention measures, which were largely developed for a different context (like intravenous drug use), may not be as effective in addressing the current modes of transmission, which are increasingly sexual.
The Malaysian AIDS
Council and the Ministry of Health are urging for a review of current
prevention strategies and increased efforts to address the rising number of HIV
infections among this age group.
The Ministry of Health faces challenges in implementing prevention and treatment programs due to legal restrictions that prevent minors from accessing HIV testing and treatment without parental consent. The Ministry of Health is expanding HIV self-testing kits through NGOs and the Malaysian AIDS Council to increase community screening.
PHYSTA® as the Global Gold Standard for Natural CD4 Enhancement
1. Global Comparison: No Other Herbal Extract Matches
PHYSTA®
Scientific Fact: No other herbal supplement worldwide
has demonstrated statistically significant CD4 T-cell enhancement in a rigorous,
published clinical trial like PHYSTA®.
Global Comparison
Supplement |
Origin |
CD4 Effect |
Clinical
Evidence |
Study Duration |
PHYSTA |
Malaysia |
↑↑ 10-15%
CD4 (p < 0.05) |
Randomized,
double-blind, place-controlled (TMDU) |
12 weeks |
AHCC (Mushroom
extract) |
Japan |
Mild NK- cell
boost (no CD4 proof) |
Small HIV trials
(weak evidence) |
3-6 months |
Beta-Glucans
(Yeast / Mushroom) |
Global |
Innate immunity
only |
No CD4 –
specific data |
Weeks |
Cat’s Claw (
Uncaria tomentosa) |
Peru |
Anti-inflammatory ( no CD4 rise) |
Anecdotal only |
N/A |
Global Comparison
HUMAN IMMUNODEFICIENCY VIRUSES
2. Why PHYSTA® Stands Alone
a. Superior Research Backing
i. TMDU (Tokyo Medical & Dental University) is a Top
10 Japan medical research hub their endorsement adds major credibility.
ii.Study Design Flawless: Randomized,
placebo-controlled, 12-week duration (long enough to rule out placebo
effects).
b. Tangible CD4 Boosting Mechanism
Unlike vague "immune support" claims from
other herbs, PHYSTA® showed direct CD4 elevation via:
i. Possible thymic peptide stimulation (rare in adults).
ii. Anti-apoptotic
effects (reducing T-cell death).
iii. Testosterone
modulation (indirectly supports CD4 longevity).
c. Safety & Stability
i. No adverse effects on platelets, liver, or kidneys
(critical for long-term use).
ii. Non-hormonal (unlike synthetic immune
boosters).
3. Practical Applications. For Whom?
✔ Middle-aged/elderly
adults (combatting age-related immune decline).
✔ Mild
immunodeficiencies (e.g., recurrent infections, slow wound healing).
✔ HIV
patients (adjunct only) must still use ART but may benefit from extra CD4
support.
Protocol. 200 mg/day PHYSTA (used in the study - normal people). HIV daily intake after food 2 morning, 2 noon & 2 night. ( max 8 cap ).
Best taken with fats (lipophilic compounds enhance
absorption).
Expected Results Timeline
a. 4–6 weeks: Initial CD4 uptick (study showed gradual rise).
b. 12 weeks: Peak enhancement (~10–15% above baseline).
4. "Why Haven’t Other Herbs Shown This?"
Most immune herbs target innate immunity (macrophages, NK cells) not adaptive (T-cells).
PHYSTA’s uniqueness: Eurycoma longifolia contains novel quassinoids (e.g., eurycomanone) with T-cell-specific effects.
"Is This Too Good to Be True?"
No but it’s not a "cure":
Modest CD4 gains won’t replace drugs for severe immunodeficiency. Works best as preventive maintenance.
5. Future Directions - next Research Steps
HIV-specific trials (can PHYSTA® slow CD4 decline alongside ART?).
Commercial Potential - Malaysia could dominate the immune-booster market with PHYSTA® as its flagship. Pharma partnerships to develop standardized extracts for hospitals.
Nu-Caffe: More Than Just Coffee – It's a
Scientific Sip of Strength!
Ever wonder what makes Nu-Caffe so unique? It's
not just the rich aroma or smooth taste — it's what’s inside that makes all the
difference.
🔬 Backed by PHYSTA® Tongkat Ali, a clinically
standardized extract, Nu-Caffe does more than energize you. It helps your body
at the cellular level — by increasing CD4 cells, the essential commanders of
your immune system.
✅ What are CD4 cells?
They’re white blood cells that help fight
infections, support immunity, and regulate your body’s natural defenses.
📈 Why is this important?
"PHYSTA® is the world’s first and only natural CD4 enhancer with clinical proof. While other herbs make vague 'immune-boosting' claims, PHYSTA® delivers measurable T-cell gains setting a new standard for evidence-based botanicals. Malaysia’s Biotropics and TMDU have achieved what no other country or herb has: validated, drug-grade immune modulation from a plant."
Adopt PHYSTA® for preventive immune care (especially 40+ adults).
No comments:
Post a Comment